Market revenue in 2023 | USD 6.6 million |
Market revenue in 2030 | USD 12.2 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Product |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 60.61% in 2023. Horizon Databook has segmented the Norway multiomics market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing funding related to gene therapy in the country is expected to create growth opportunities for market growth. For instance, in December 2022, Haapaniemi group approved around USD 2 million (NOK 20 million) to develop a clinical trial with genome-edited T cells.
This initiative aims to develop Tcell therapy for STwAT1 Gain-of-Function disorder and other immunodeficiencies. On the other hand, the Norwegian government recognized the importance of multiomics research and provided support through funding and initiatives aimed at promoting scientific research & innovation.
For instance, the Clinical and Multi-omic (CAMO) cohort, a part of the Norwegian Women and Cancer (NOWAC) study performed in February 2023, involved collecting comprehensive epidemiological and clinical information, along with blood and tumor samples, to establish a cohort conducive to integrated research approaches.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway multiomics market , including forecasts for subscribers. This country databook contains high-level insights into Norway multiomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account